- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01062789
Optical Breath-hold Control System for Image-guided Procedures (OBC)
May 16, 2011 updated by: Mayo Clinic
Use of an Optical Breath-hold Control (OBC) System for Image-guided Interventional Radiology Procedures: A Feasibility Study
The objective or our study is to test the feasibility of a new optical-based breath-hold control (OBC) system for monitoring breath-hold levels and providing patient feedback during CT-guided biopsies of the lung and upper abdomen where respiratory motion is a problem.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
- Specific Aim #1: To further test the feasibility of the new OBC system for guiding accurate and reproducible breath-hold levels that correlate with internal target position in human volunteers. Hypothesis: The OBC system is as good as or better than the currently used IBC system with regard to accuracy and reproducibility of a reference breath-hold level.
- Specific Aim #2: To compare the use of 2 optical-based belts (wrapped around the chest and abdomen) versus 1 optical-based belt (wrapped around the chest or abdomen, depending on which region expands the most during respiration) with regard to accuracy and reproducibility of a pre-determined reference breath-hold level in a subset of patients (prone and/or obese). Hypothesis: The use of 2 optical-based belts allows increased accuracy and reproducibility of a pre-determined reference breath-hold level compared with the use of only one belt in this subset of patients.
- Specific Aim #3: To test the clinical feasibility of the new OBC system in patients undergoing CT-guided biopsy of the lung or upper abdomen where respiratory motion is a problem. Hypothesis: The OBC system is as good as or better than the currently used IBC system with regard to the accuracy and reproducibility of the reference breath-hold and ease of use.
Study Type
Interventional
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55901
- Mayo Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients scheduled for a CT-guided lung or upper abdomen biopsy (including lesions in the liver, pancreas, stomach, kidneys, adrenals, spleen, or in the peritoneum at or above the level of the kidneys) on the SMH-CT-3M scanner when either Dr. Carlson or Dr. Bender are scheduled.
- Lesions will need to measure 3 cm or less in maximum dimension and cannot be affixed to the chest or abdominal wall.
Exclusion Criteria:
- Inability to cooperate with breath-holding (including cognitive impairment, poor pulmonary function that inhibits patients from being able to hold their breath for at least 10 seconds)
- Patients with bleeding diatheses (platelets < 50,000, International Normalized Ratio > 1.5, or activated partial thromboplastin time > twice normal)
- Lesions that abut the pleura or abdominal wall for a distance greater than 3 cm (these lesions were assumed to be fixed in position and less likely to be affected by respiratory motion).
- Patients with implanted medical devices (pacemakers) (this exclusion is based on the Division of Engineering Safety Review-enclosed in application)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Use of an optical breath-hold control device
This is a feasibility study that will use this new device in place of a different bellows-based breath-hold control device for a series patients undergoing CT-guided lung biopsy.
The new belt will be used in all patients in our study.
|
The OBC system was designed to replace the IBC rubber bellows respiration sensor system that we are currently using for CT-guided lung biopsies.
Unlike the IBC, the OBC is 1) unaffected by temperature changes, 2) has a linear sensitivity (for easier use and better accuracy), 3) has no pneumatic purge time when setting reference breath-hold level (reducing the chance of an inappropriate reference), 4) has no pneumatic cable that can occasionally interfere and get pinched during procedures, 5) is ambulatory (so patients can more easily familiarize themselves with the device before the procedure), 6) is capable of indicating proper fitting tension, 7) allows for easier binding (wireless pairing with other system components), and 8) is significantly less expensive (and possibly disposable).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Ability to monitor patient respiration (return of target to same anatomical position)
Time Frame: Measured daily for each individual procedure
|
Measured daily for each individual procedure
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Needle Placement Time
Time Frame: Measured daily for each individual procedure
|
Measured daily for each individual procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stephanie K Carlson, MD, Mayo Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2010
Primary Completion (Actual)
May 1, 2011
Study Completion (Actual)
May 1, 2011
Study Registration Dates
First Submitted
January 28, 2010
First Submitted That Met QC Criteria
February 3, 2010
First Posted (Estimate)
February 4, 2010
Study Record Updates
Last Update Posted (Estimate)
May 17, 2011
Last Update Submitted That Met QC Criteria
May 16, 2011
Last Verified
May 1, 2011
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 09-004069
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiration
-
Medical University InnsbruckCompletedPositive-Pressure Respiration | Respiration; ArtificialAustria
-
Yeditepe UniversityNot yet recruitingChild | Functional Capacity | Music | Posture | Respiration DisorderTurkey (Türkiye)
-
University of OuluTampere UniversityCompleted
-
Tianjin Medical University General HospitalCompleted
-
Respinor ASEuropean CommissionCompletedRespiration, ArtificialFrance
-
Università degli Studi di FerraraAalborg UniversityCompletedArtificial RespirationItaly
-
University Hospital, GenevaUnknownRespiration, ArtificialSwitzerland
-
Hospital Donación Francisco SantojanniActive, not recruitingObstructive Airway DiseasesArgentina
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruiting
-
Sanatorio Anchorena San MartinJavier Hernán Dorado; Joaquin PerezCompletedRespiration, ArtificialArgentina
Clinical Trials on Optical breath-hold control system (OBC)
-
Istanbul Gelisim UniversityNot yet recruitingCognitive Performance | Sport PhysiologyTurkey (Türkiye)
-
AstraZenecaCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
University Hospitals Cleveland Medical CenterTerminated
-
Novartis PharmaceuticalsActive, not recruitingChronic Spontaneous UrticariaIndia, Taiwan, Netherlands, Italy, France, Spain, Switzerland, Germany, Thailand, Bulgaria, United Kingdom, Argentina, Malaysia, Vietnam, Slovakia, Poland, Canada, Hungary, Mexico, Czechia, South Korea, Turkey (Türkiye), Brazil
-
Children's National Research InstituteActive, not recruiting
-
Le Bonheur Children's HospitalUniversity of TennesseeCompleted
-
Taif UniversityRecruitingChronic Low Back Pain (CLBP)Saudi Arabia
-
Chang Gung UniversityChang Gung Memorial Hospital; National Science and Technology Council; National...CompletedHealthy Volunteers | Pharmacogenomic Drug Interaction | Aerosol Therapy | Inhaled Drug DoseTaiwan
-
Brunel UniversityUniversity of Sao PauloUnknownBreathlessness | Hyperventilation Syndrome | Respiration Disorder | Breath ShortnessUnited Kingdom